1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. North America Myopia Treatment Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. North America Myopia Treatment Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. North America Myopia Treatment Market Regional Analysis
6.2 North America Myopia Treatment Market Revenue 2020-2030 (US$ Million)
6.3 North America Myopia Treatment Market Forecast Analysis
7. North America Myopia Treatment Market Analysis – by Type
7.1 High Myopia
- 7.1.1 Overview
- 7.1.2 High Myopia: North America Myopia Treatment Market – Revenue and Forecast, 2020-2030 (US$ Million)
7.2 Degenerative Myopia
- 7.2.1 Overview
- 7.2.2 Degenerative Myopia: North America Myopia Treatment Market – Revenue and Forecast, 2020-2030 (US$ Million)
7.3 Progressive Myopia
- 7.3.1 Overview
- 7.3.2 Progressive Myopia: North America Myopia Treatment Market – Revenue and Forecast, 2020-2030 (US$ Million)
8. North America Myopia Treatment Market Analysis – by Treatment
8.1 Low-Dose Atropine Eye Drops
- 8.1.1 Overview
- 8.1.2 Low-Dose Atropine Eye Drops: North America Myopia Treatment Market – Revenue and Forecast, 2020-2030 (US$ Million)
8.2 Contact Lenses
- 8.2.1 Overview
- 8.2.2 Contact Lenses: North America Myopia Treatment Market – Revenue and Forecast, 2020-2030 (US$ Million)
8.3 Ortho-K
- 8.3.1 Overview
- 8.3.2 Ortho-K: North America Myopia Treatment Market – Revenue and Forecast, 2020-2030 (US$ Million)
8.4 Refractive Surgery
- 8.4.1 Overview
- 8.4.2 Refractive Surgery: North America Myopia Treatment Market – Revenue and Forecast, 2020-2030 (US$ Million)
9. North America Myopia Treatment Market Analysis – by End User
9.1 Hospitals and Clinics
- 9.1.1 Overview
- 9.1.2 Hospitals and Clinics: North America Myopia Treatment Market – Revenue and Forecast, 2020-2030 (US$ Million)
9.2 Specialty Clinics
- 9.2.1 Overview
- 9.2.2 Specialty Clinics: North America Myopia Treatment Market – Revenue and Forecast, 2020-2030 (US$ Million)
9.3 Refractive Surgery Centers
- 9.3.1 Overview
- 9.3.2 Refractive Surgery Centers : North America Myopia Treatment Market – Revenue and Forecast, 2020-2030 (US$ Million)
10. North America Myopia Treatment Market – North America Analysis
10.1 Overview
10.2 North America
- 10.2.1 North America Myopia Treatment Market Breakdown, by Key
Country, 2023 and 2030 (%)
- 10.2.1.1 North America Myopia Treatment Market – Revenue and
Forecast Analysis – by Country
- 10.2.1.1 US:
North America Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million)
- 10.2.1.1.1 US: North America Myopia Treatment Market Breakdown, by Type
- 10.2.1.1.2 US: North America Myopia Treatment Market Breakdown, by Treatment
- 10.2.1.1.3 US: North America Myopia Treatment Market Breakdown, by End User
- 10.2.1.2 Canada:
North America Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million)
- 10.2.1.2.1 Canada: North America Myopia Treatment Market Breakdown, by Type
- 10.2.1.2.2 Canada: North America Myopia Treatment Market Breakdown, by Treatment
- 10.2.1.2.3 Canada: North America Myopia Treatment Market Breakdown, by End User
- 10.2.1.3 Mexico :
North America Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million)
- 10.2.1.3.1 Mexico : North America Myopia Treatment Market Breakdown, by Type
- 10.2.1.3.2 Mexico : North America Myopia Treatment Market Breakdown, by Treatment
- 10.2.1.3.3 Mexico : North America Myopia Treatment Market Breakdown, by End User
11. Competitive Landscape
11.1 Heat Map Analysis
11.2 Company Positioning and Concentration
12. Industry Landscape
12.1 Overview
12.2 Market Initiative
12.3 Partnerships and Collaborations
12.4 Other Developments
13. Company Profiles
13.1 Bausch Health Companies Inc
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 Alcon AG
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 CooperVision Inc
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 Johnson & Johnson Vision Care Inc
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 Topcon Healthcare Solutions Inc
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 Ziemer Ophthalmic Systems AG
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 Nidek Co Ltd
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 Eyes Vision SL
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
13.9 Haag-Streit AG
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments
13.10 Carl Zeiss AG
- 13.10.1 Key Facts
- 13.10.2 Business Description
- 13.10.3 Products and Services
- 13.10.4 Financial Overview
- 13.10.5 SWOT Analysis
- 13.10.6 Key Developments
14. Appendix
14.1 About Business Market Insights
14.2 List of Abbreviations